Hepatitis B surface antigen (HBsAg) prevalence (%) in Myanmar
Myanmar: Hepatitis B surface antigen (HBsAg) prevalence was 1.3% in 2024. ▼ Falling
Latest (2024)
1.3%
Change on year
up 8.3%
World rank
24th
of 194 countries
All-time high
1.7%
in 2016
All-time low
0.8%
in 2019
Years of data
10
2015–2024
Hepatitis B surface antigen (HBsAg) prevalence in Myanmar, 2015–2024
Source: World Health Organization, Global Health Observatory.
Analysis
Myanmar recorded 1.3% for hepatitis b surface antigen (hbsag) prevalence in 2024.
The figure is up 8.3% on the previous year and down 18.8% over ten years.
Over the whole period, hepatitis b surface antigen (hbsag) prevalence in Myanmar peaked at 1.7% in 2016 and was at its lowest, 0.8%, in 2019.
That places Myanmar 24th out of 194 countries with data for 2024, putting it in the top quarter.
Hepatitis B surface antigen (HBsAg) prevalence in Myanmar, year by year
| Year | Value | Change |
|---|---|---|
| 2015 | 1.6% | — |
| 2016 | 1.7% | +6.2% |
| 2017 | 1.3% | -23.5% |
| 2018 | 1.0% | -23.1% |
| 2019 | 0.8% | -20.0% |
| 2020 | 0.8% | +0.0% |
| 2021 | 1.0% | +25.0% |
| 2022 | 1.1% | +10.0% |
| 2023 | 1.2% | +9.1% |
| 2024 | 1.3% | +8.3% |
Myanmar compared with similar countries
- Myanmar's 1.3% is above the median for lower middle income countries, which is 0.6%, 2.2× the median. (47 countries reporting)
- Myanmar's 1.3% is above the median for East Asia & Pacific, which is 0.6%, 2.2× the median. (30 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 1.3% | 0.8% | 1.7% | 5 |
| 2020s | 1.1% | 0.8% | 1.3% | 5 |
Countries ranked near Myanmar
More health data for Myanmar
- Un projection of annual infant deaths, annual growth rate -2.11 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.1576 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,398 deaths per 1,000 people (2090)
- Number of infants who die before age 1 2,973 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 7 (2025)
- Population ages 00-04, female, annual growth rate -0.759 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0387 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.8351 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is hepatitis b surface antigen (hbsag) prevalence in Myanmar?
- Hepatitis b surface antigen (hbsag) prevalence in Myanmar was 1.3% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest hepatitis b surface antigen (hbsag) prevalence recorded in Myanmar?
- The highest recorded value was 1.7% in 2016.
- What is the lowest hepatitis b surface antigen (hbsag) prevalence recorded in Myanmar?
- The lowest recorded value was 0.8% in 2019.
- How does Myanmar rank for hepatitis b surface antigen (hbsag) prevalence?
- Myanmar ranks 24th out of 194 countries with data for 2024.
- Is hepatitis b surface antigen (hbsag) prevalence rising or falling in Myanmar?
- Over the last ten years it is down 18.8%. The long-run trend across the full record is falling.
- Where does this Myanmar data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 10 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).